Novozymes is forecast to grow earnings and revenue by 14.1% and 6.8% per annum respectively. EPS is expected to grow by 14.1% per annum. Return on equity is forecast to be 8.6% in 3 years.
Key information
14.1%
Earnings growth rate
14.13%
EPS growth rate
Chemicals earnings growth
30.6%
Revenue growth rate
6.8%
Future return on equity
8.57%
Analyst coverage
Good
Last updated
03 Jul 2026
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
BATS-CHIXE:NSISBC - Analysts future estimates and past financials data (EUR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
5,101
970
984
1,505
15
12/31/2027
4,757
854
826
1,381
16
12/31/2026
4,432
732
752
1,266
16
3/31/2026
4,199
597
774
1,282
N/A
12/31/2025
4,158
584
751
1,222
N/A
9/30/2025
4,142
547
745
1,123
N/A
6/30/2025
4,098
565
569
918
N/A
3/31/2025
4,058
459
586
950
N/A
12/31/2024
3,834
306
660
1,020
N/A
9/30/2024
3,471
314
634
941
N/A
6/30/2024
3,047
283
599
891
N/A
3/31/2024
2,636
334
422
692
N/A
12/31/2023
2,402
406
281
557
N/A
9/30/2023
2,390
430
169
485
N/A
6/30/2023
2,382
460
83
436
N/A
3/31/2023
2,390
487
83
476
N/A
12/31/2022
2,360
494
150
539
N/A
9/30/2022
2,268
460
206
554
N/A
6/30/2022
2,186
418
262
539
N/A
3/31/2022
2,090
416
337
530
N/A
12/31/2021
2,009
423
379
546
N/A
9/30/2021
1,958
427
461
593
N/A
6/30/2021
1,914
409
432
564
N/A
3/31/2021
1,883
389
443
577
N/A
12/31/2020
1,883
380
459
585
N/A
9/30/2020
1,920
415
442
521
N/A
6/30/2020
1,955
405
465
536
N/A
3/31/2020
1,968
439
407
482
N/A
12/31/2019
1,924
422
N/A
428
N/A
9/30/2019
1,923
411
N/A
460
N/A
6/30/2019
1,917
434
N/A
505
N/A
3/31/2019
1,922
417
N/A
477
N/A
12/31/2018
1,927
432
N/A
493
N/A
9/30/2018
1,924
427
N/A
515
N/A
6/30/2018
1,915
429
N/A
490
N/A
3/31/2018
1,920
423
N/A
501
N/A
12/31/2017
1,952
419
N/A
546
N/A
9/30/2017
1,958
421
N/A
533
N/A
6/30/2017
1,934
412
N/A
522
N/A
3/31/2017
1,919
414
N/A
547
N/A
12/31/2016
1,902
410
N/A
517
N/A
9/30/2016
1,864
394
N/A
488
N/A
6/30/2016
1,883
394
N/A
437
N/A
3/31/2016
1,883
384
N/A
450
N/A
12/31/2015
1,876
378
N/A
447
N/A
9/30/2015
1,840
366
N/A
395
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NSISBC's forecast earnings growth (14.1% per year) is above the savings rate (3.4%).
Earnings vs Market: NSISBC's earnings (14.1% per year) are forecast to grow faster than the UK market (11.5% per year).
High Growth Earnings: NSISBC's earnings are forecast to grow, but not significantly.
Revenue vs Market: NSISBC's revenue (6.8% per year) is forecast to grow faster than the UK market (4.7% per year).
High Growth Revenue: NSISBC's revenue (6.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NSISBC's Return on Equity is forecast to be low in 3 years time (8.6%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/06 03:24
End of Day Share Price
2026/07/06 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novozymes A/S is covered by 26 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.